会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Transdermal drug delivery device using a membrane-protected microporous
membrane to achieve delayed onset
    • 透皮给药装置使用膜保护微孔膜实现延迟发作
    • US5273756A
    • 1993-12-28
    • US748935
    • 1991-08-23
    • Renee A. FallonSubbu S. VenkatramanGary W. Cleary
    • Renee A. FallonSubbu S. VenkatramanGary W. Cleary
    • A61F13/02A61K9/70
    • A61K9/703A61K9/7084
    • A delayed onset transdermal drug delivery device exhibiting a delay period of at least eight hours comprising a laminated composite of (12) a top backing layer; (13) a pressure rupturable layer underlying (12); (14) a reservoir of a solution of drug in al liquid vehicle between (12) and (13); (16) a wick layer underlying (13) for dispersing the drug once (13) is ruptured; (17) a first adhesive layer underlying (16) that is permeable to the drug; (18) a first polymer membrane that is permeable to drug but substantially impermeable to the adhesive of (17); (19) a microporous membrane underlying (18) which is itself impermeable to the drug and whose pores are unfilled; (20) a second polymer membrane that underlies the microporous membrane that is permeable to drug but substantially impermeable to the adhesive of (21) below; and (21) a second adhesive layer underlying (20) that is permeable to the drug.
    • 延迟发作的透皮药物递送装置显示至少8小时的延迟时间,其包括层压复合材料(12)顶层背衬层; (13)位于(12)下面的压力破裂层; (14)在(12)和(13)之间的液体载体中的药物溶液的储存器; (16)用于分散药物(13)的(13)下方的芯层破裂; (17)对药物是可渗透的第一粘合剂层(16); (18)第一聚合物膜,其对于药物是可渗透的但对(17)的粘合剂基本上不可渗透; (19)下面的微孔膜(18),其本身对于药物是不透气的,并且其孔未填充; (20)第二聚合物膜,其位于可渗透药物但基本上不渗透下面的(21)的粘合剂的微孔膜之下; 和(21)可渗透药物的第二粘合剂层(20)。